Transparency is the main concern
however, combining hypoxia-targeted therapies with existing modalities such as immunotherapy, radiotherapy, or anti-angiogenic agents may offer synergistic effects (311313)
A prespecified analysis found the kidney effect to be directionally consistent regardless of baseline SGLT2i use, with no significant treatment-by-subgroup interaction, although only a small minority of participants were taking an SGLT2i at entry, so the combination subgroup was underpowered and does not by itself establish additive benefit
4 In addition, ongoing studies show promise that GLP-1 drugs may improve outcomes for psychological impairments, addictions, Alzheimer's disease, and Parkinson's disease
RNA isolation and quantitative real-time PCR